一品红(300723.SZ)子公司获得复方聚乙二醇电解质散(Ⅲ)注册证书

Core Viewpoint - The company Yipinhong (300723.SZ) has received the drug registration certificate for Compound Polyethylene Glycol Electrolyte Powder (III) from the National Medical Products Administration, allowing it to sell this product in the domestic market, which enhances its product pipeline and core competitiveness [1] Group 1 - The registration certificate is specifically for the use of the product in bowel cleansing preparation for patients prior to procedures such as endoscopy, radiological examinations, and colorectal surgery, applicable to adults [1] - This approval signifies the company's capability to market this specific drug formulation in China, thereby expanding its product offerings [1] - The introduction of this product is expected to strengthen the company's competitive edge in the pharmaceutical industry [1]